Search
Bamlanivimab
go.drugbank.com/drugs/DB15718ApprovedInvestigationalBamlanivimab (LY-CoV555, also known as LY3819253), is a synthetic monoclonal antibody (mAb) derived from one of the first blood samples in the United States from a patient who recovered from COVID-19. … [L15316, L15321] Under the EUA granted in February 2021, bamlanivimab is used in combination with [etesevimab] to treat mild to moderate COVID-19 in adults and pediatric patients who are at high risk
Peramivir
go.drugbank.com/drugs/DB06614ApprovedInvestigationalfor no more than two days. … The injectable intravenous formulation of peramivir was approved by the FDA in September 2017 for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older who have been symptomatic
Tirzepatide
go.drugbank.com/drugs/DB15171ApprovedInvestigational[L41820] Later, it was approved under a different brand name ZEPBOUND on November 8, 2023, for the chronic weight management in adults with obesity or overweight with at least one weight-related condition … [A246260] Tirzepatide comprises a 39 amino acid linear synthetic peptide conjugated to a C20 fatty diacid moiety.
Iron sucrose
go.drugbank.com/drugs/DB09146ApprovedInvestigational(hemodialysis or peritoneal) and those who do not require dialysis. … Due to less side effects than iron dextran, iron sucrose is more preferred in chronic kidney disease patients.
Mixtures: VP-HEME One, VP-HEME OneBeta carotene
go.drugbank.com/drugs/DB06755ApprovedNutraceuticalBeta-carotene, with the molecular formula C40H56, belongs to the group of carotenoids consisting of isoprene units. … Beta-carotene is composed of two retinyl groups. It is an antioxidant that can be found in yellow, orange and green leafy vegetables and fruits.
Mixtures: Vege Swiss One Multivitamin W Chel Mins Tab, Formula OLidocaine
go.drugbank.com/drugs/DB00281ApprovedInvestigationalVet approvedIn doing so, however, it can block or decrease muscle contractile, resulting in effects like vasodilation, hypotension, and irregular heart rate, among others [F4349, L5930, L5948]. … It ultimately elicits its numbing activity by blocking sodium channels so that the neurons of local tissues that have the medication applied on are transiently incapable of signaling the brain regarding
Mixtures: Exigence One Patch, Exigence One PatchProducts: Xylocard One Gm Additive Unit 20% Inj, CATHEJELL LIGNOCAINE GEL 2% w/wUbidecarenone
go.drugbank.com/drugs/DB09270ApprovedInvestigationalNutraceuticalFrom its name (Q10), the Q refers to the constitutive quinone group, and 10 is related to the number of isoprenyl subunits in its tail. … [L1062] Ubidecarenone is sold as a dietary supplement and is not FDA approved as a drug - it is not meant to treat, cure or prevent any disease.
Mixtures: Shine CO-Q Plus, Co-q10 M.R.B. 60mgSynonyms: Co Enzyme Q10, Co-Enzyme Q10Avalglucosidase alfa
go.drugbank.com/drugs/DB16099ApprovedInvestigational[A232960] On August 6, 2021, avalglucosidase alfa-ngpt was approved by the FDA under the market name Nexviazyme to treat patients one year of age and older with late-onset Pompe disease. … First developed by Sanofi Genzyme, avalglucosidase alfa is a chemically modified version of [alglucosidase alfa], where synthetic bis-phosphorylated oligosaccharides were attached to the structure to improve
Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen
go.drugbank.com/drugs/DB10285ApprovedInvestigationalIt is contained in the suspension of Trumenba, which is a vaccine is composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily … A and one from subfamily B (A05 and B01, respectively).
Rasagiline
go.drugbank.com/drugs/DB01367ApprovedInvestigationalRasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: RASAGILINA DOC GENERICI